Breaking: Evelo Biosciences and Bio-Rad Agree on Sublease Termination and Surrender Deal
- July 20th, 2023
- 362 views
According to a regulatory filing with the SEC, Evelo Biosciences, Inc. (Nasdaq: EVLO) has entered into a Sublease Termination and Surrender Agreement with Bio-Rad Laboratories, Inc. (NYSE: BIO). The agreement terminates the Sublease, which provided Evelo Biosciences with approximately 40,765 square feet of office and laboratory space in Cambridge, Massachusetts. The termination will become effective on September 15, 2023.
As part of the agreement, Evelo Biosciences will pay Bio-Rad a one-time termination payment of $523,556. Additionally, Bio-Rad is entitled to draw on a letter of credit for $850,000 and retain the proceeds. Further, there may be an additional payment of up to $2,500,000 if Evelo Biosciences completes a Monetization Event.
In after-hours, $EVLO is currently trading at $11.24 (+14.00%), and $BIO is at $400.00 (+0.45%)
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
Treasury Targets Family Members and Associates of Maduro Regime
December 20th, 2025Herbal Works Inc. Supports President Trump's Order Easing Restriction on Cannabis
December 18th, 2025Herbal Works Inc. Plans on Expansion of Product Line in 2026
December 18th, 2025December 17th, 2025Crown Equity Holdings Inc. Announces Changes to Board of Directors
December 16th, 2025
Member Login